Featured News Headlines
Aptos CEO Heads to Capitol Hill as Token Rallies Toward $5
Aptos CEO – Avery Ching, CEO of Aptos Labs, is scheduled to testify before the U.S. House Committee on Agriculture on June 4, in a congressional hearing titled “American Innovation and the Future of Digital Assets: From Blueprint to a Functional Framework.” The announcement sparked renewed interest in Aptos (APT), with the token surging nearly 5% following the news.
APT Price Surges Following Testimony News
After the official Aptos X (formerly Twitter) account confirmed Ching’s participation, APT’s price rose from $4.68 to a peak of $4.96, briefly approaching the psychological $5 threshold. As of press time, APT trades at $4.93, marking a 4.5% increase in the last 24 hours. Its market capitalization now stands at $3.1 billion, and daily trading volume has jumped 20.9%, signaling growing market engagement.
Aptos Labs to Represent the L1 Ecosystem
In a statement, Ching said he is “looking forward to sharing how Aptos Labs and the broader L1 blockchain ecosystem can power the next era of the decentralized internet.” His testimony is expected to cover real-world blockchain use cases, token utility, and the urgent need for regulatory clarity in the U.S. crypto space.
High-Profile Witness Panel Announced
Ching joins three other prominent figures on the witness list: Michael Piwowar, former SEC Commissioner; Chelsea E. Pizzola, former CFTC General Attorney; and Ryne Miller, Co-Chair of Lowenstein’s Crypto Group.
Aptos Expands Ecosystem and Faces ETF Delays
In April, Aptos Foundation announced a strategic investment in Universal Health Token (UHT), supporting blockchain-based health tracking using AI. Meanwhile, Bitwise’s Aptos ETF application, filed on March 6, remains under review amid broader SEC delays on crypto ETF approvals.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Cryptocurrencies and stocks, particularly in micro-cap companies, are subject to significant volatility and risk. Please conduct thorough research before making any investment decisions.
